Total Knee Replacement . . . or Not? Advanced Orthopedics and Sports Medicine Institute Surgeon Presents Latest Information at Free Seminar.

Dr. Manuel T. Banzon of Advanced Orthopedics and Sports Medicine Institute in Freehold, New Jersey will hold a free, educational seminar to discuss knee replacements at Bartley Healthcare on June 15 at 7 p.m. - June 15, 2009 - Advanced Orthopedics and Sports Medicine Institute, PC

Lankenau Institute for Medical Research Investigator Receives March of Dimes Grant: Research Focused on Congenital Defects of the Eye in Newborns Using a Stem Cell Model

Dr. Mindy George-Weinstein, Professor at the Lankenau Institute for Medical Research (LIMR), in collaboration with Dr. Sue Menko, Professor at Thomas Jefferson University, received a three-year grant in the amount of $264,410 from the March of Dimes to study the development of eye defects that may lead to cataracts, glaucoma, increased sensitivity to light, squinting or blindness in newborns. - June 13, 2009 - Lankenau Institute for Medical Research

S.L.E. Lupus Foundation, 1st Lupus Organization Ever Selected as Charity Partner for ING New York City Marathon

S.L.E. Lupus Foundation, 1st Lupus Organization Ever Selected as Charity Partner for ING New York City Marathon

The S.L.E. Lupus Foundation has been selected as an official charity for the ING New York City Marathon 2009, making it the first lupus organization ever to host a team in this famous race that has a broadcast reach to more than 300 million people worldwide. The Foundation currently has 25 openings for runners to participate in their “Team Life Without Lupus.” - June 09, 2009 - S.L.E. Lupus Foundation

ENCO Pharmaceutical Development Announces Addition of Keith Hurley as Vice-President of Sales and Marketing

ENCO Pharmaceutical Development, Inc. is pleased to announce the addition of Mr. Keith Hurley to its staff as Vice-President of Sales and Marketing. - June 06, 2009 - Enco Pharmaceutical Development, Inc.

CoreRx, Inc. Expanding Tampa Pharmaceutical Formulation Development Headquarters

Formulation Development firm CoreRx announces new facility which will add capacity, additional capabilities to growing laboratory in order to meet growing customer demands. - June 05, 2009 - CoreRx, Inc.

Colorado BioScience Association Applauds Governor Bill Ritter’s Signing of House Bills 1035 and 1105, Ensuring Colorado’s Position as a Thriving Location for Bioscience

Colorado Governor Bill Ritter has signed HB 1035 (expanding sales and use tax for medical device companies) and HB 1105 (Angel Investment Tax Credit), ensuring Colorado’s position as a thriving location for bioscience and emerging technology companies. The announcement is made by John Collar,... - June 04, 2009 - Colorado BioScience Association

Clinical Trials in Russia. 1st Quarter 2009

On June 01, 2009 Synergy Research Group (SynRG), a Russia-based CRO, presented the English version of SynRG Orange Paper Q1 2009, a regular analytical report on the clinical trial market in Russia. The report is Free and contains hundreds of figures as well as dozens of tables and pictures covering various aspects of the Russian clinical trial market. - June 03, 2009 - Synergy Research Group

Advanced Biotechnologies, Inc. (ABI) Adds UV-Inactivated Purified Whole Virus Product to Aid in Research of Human Influenza

ABI adds (H2N2) Purified Whole Virus, UV-Inactivated for use in H2N2 subtype-specific protein-based testing. Catalog # 10-126-000 - June 01, 2009 - Advanced Biotechnologies, Inc.

Advanced Biotechnologies, Inc. (ABI) Adds Cytomegalovirus (CMV) β-PL Inactivated Purified Whole Virus Product

Cytomegalovirus (CMV) AD169, Purified Whole Virus was inactivated by treatment with Beta-propiolactone (β-PL). β-PL is a DNA alkylating agent that has been shown to be effective in the inactivation of a virus. It chemically modifes viral DNA without affecting the immunogenicity or protein... - May 30, 2009 - Advanced Biotechnologies, Inc.

Colorado Again Confirmed as Top Bioscience State by National Rankings & Venture Capital Funding Activity

It’s been another outstanding year for Colorado in the highly competitive state rankings arena. FierceBiotech included Colorado in its top five regions targeting biotech companies. Further, Colorado now ranks 8th in VC funding for biotech firms and 10th for medical device and equipment firms, as recently reported by Genome Technology. Colorado’s venture capital success was vividly demonstrated when Boulder-based Clovis recently launched with an impressive $145 million in start-up funding. - May 29, 2009 - Colorado BioScience Association

IonSense to Present Simplified DART Source with iPod Control at the American Society for Mass Spectrometry Annual Conference

Enables Direct Analysis of Gas, Liquids and Solids in Seconds - May 28, 2009 - IonSense, Inc.

Satellite Office of Advanced Orthopedics and Sports Medicine Institute in Middlesex County, New Jersey, Launched by Assemblywoman and Monroe Town Council Members

Local dignitaries, including Assemblywoman Linda Greenstein and several Monroe Town Council Members, gathered to launch the Middlesex County satellite office of Advanced Orthopedics and Sports Medicine (AOSMI) and wish the orthopedic surgeons and staff well. - May 27, 2009 - Advanced Orthopedics and Sports Medicine Institute, PC

New Firm, Dust DNA, Combats Sick Building Syndrome in Homes

Thousands of allergy sufferers could find significant relief simply by making a few adjustments in their homes, according to Dust DNA, a new firm that tests for allergens within residential structures. - May 26, 2009 - Dust DNA

Columbia Analytical Develops Protocol for Testing Corrosion and Odor in Chinese Drywall

Columbia Analytical announces a reliable test protocol for identifying odor and corrosion problems in drywall. The tests identify problems with drywall, initially reported as "Chinese drywall." - May 23, 2009 - Columbia Analytical Services

Batten Disease Support and Research International Awareness Days

Batten Disease Support and Research Association is holding its annual Batten Disease Awareness Days on June 6 & 7, 2009. - May 23, 2009 - Batten Disease Support and Research Association

Innoget Launches a New Open Innovation Portal

· Web 2.0 linking companies to the scientific community · Awarded by the Barcelona County Council as the best entrepreneur Project in the year 2008 · Red Innovation Center - Vodafone Spain, Grupo Damm, Affinity Petcare, Indo, Fluidra, Bicentury, Oryzon Genomics, the first companies to use it - May 23, 2009 - innoget

Pulmonary Hypertension Successfully Treated with Stem Cells

Zannos Grekos, MD, a featured speaker at the at the 17th Annual World Congress on Anti-Aging Medicine and Regenerative Biotechnologies, announced one year follow-up results for a pulmonary hypertension patient treated with his own activated stem cells. "It goes against traditional theory that... - May 20, 2009 - Regenocyte Therapeutic

Cartilage Restoration Center of New Jersey Opens at Advanced Orthopedics and Sports Medicine Institute in Freehold

Advanced Orthopedics and Sports Medicine Institute in Freehold, New Jersey is the site of the new Cartilage Restoration Center of New Jersey which offers exciting new technology in repairing damaged cartilage in the knee and other joints of the body. - May 17, 2009 - Advanced Orthopedics and Sports Medicine Institute, PC

MedSource Awarded Services Contract for a Phase I Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia Clinical Trial

Houston-based Contract Research Organization (CRO) to manage three-year Phase I study - May 17, 2009 - MedSource

Unimed-Midwest Introduces Splash Shield Lite Comfortable, Disposable Face Shields

New Splash Shield Lite disposable face shields are a comfortable and effective solution for dental professionals, lab and central reprocessing/sterilization workers, and dialysis centers’ face protection needs. - May 17, 2009 - Unimed-Midwest, Inc.

TrialX Wins the 2009 New York City Entrepreneur Week Business Plan Competition

TrialX, an online clinical trials matching platform, which is committed to helping patients find new medical treatments has won the prestigious ‘2009 New York City Entrepreneur Week Business Plan Competition’ (NYCENT). Organized by the NYC Entrepreneurial Community, NYCENT is a weeklong... - May 16, 2009 - Applied Informatics

Nanogen: Good News for Troubled Biotechs

With many companies filing for bankruptcy, things look bleak for Biotechs, however it isn't all bad news. - May 15, 2009 - Nanogen

MedSource Awarded Services Contract for a Phase III Epilepsy Clinical Trial

MedSource, a Contract Research Organization (CRO) providing Phase I-IV clinical trials support, announced it has been awarded a service contract to manage a 50-center, multi-national, late phase epilepsy trial. The Houston-based CRO with regional offices in Raleigh, NC, will provide Project... - May 15, 2009 - MedSource

The Only Non-Invasive Lead Testing Product is Now Available Through Many New Distributors

Following its successful product launch in March, LeadConfirm Professional, the first and only non-invasive and oral-based lead testing product in the market today, is now available to more doctors and health care professionals through a wider online distribution base. - May 13, 2009 - Confirm Biosciences

Nanogen Launches TV Campaign

Hair Loss is still largely unrecognised by the public as a serious condition, and information, especially in terms of the options available to sufferers, isn't widely available. Nanogen, manufacturers of Hair Loss treatment & Camouflage products, have launched a television campaign to encourage sufferers to address their problem. - May 09, 2009 - Nanogen

Special DNA Testing Offered in Response to Swine Influenza Epidemic

Personal genome company, BioResolve, Inc has introduced a DNA testing service that reveals an individual's innate resistance or vulnerabilities to infectious diseases, such as swine flu. The final report states an individual's ratio of surviving a worldwide pandemic with respect to the average human, and looks into all types of infectious diseases. - May 08, 2009 - BioResolve, Inc.

Bio-Synthesis, Inc. Unveils Its Latest Step Into the Future of Forensic Science

Bio-Synthesis, Inc. begins Mitochondrial DNA Testing or MtDNA, making it one of only a handful of labs to perfect the technology. MtDNA Testing allows Forensic scientist to get a profile from samples that are old or possibly damaged, where the usual technique may not be effective. - May 08, 2009 - DNA Exam (A division of Bio-Synthesis Inc.)

ENCO Analytix, Inc, Announces Name Change to ENCO Pharmaceutical Development, Inc.

ENCO Analytix, Inc. announced today that effective immediately the company name will change to ENCO Pharmaceutical Development, Inc. - May 03, 2009 - Enco Pharmaceutical Development, Inc.

Unimed-Midwest Introduces the Head Wrap with Ice Packs

Ideal for reducing pain and swelling after dental procedures, the Head Wrap includes two reusable Ice Packs (one for each cheek). This comfortable, neoprene-free wrap is reusable and washable. - May 02, 2009 - Unimed-Midwest, Inc.

New Clinical Trial Testing if Dietary Changes Can Help Patients with Crohn's Disease

The research group of Dr. James Michael Mullin, Professor at the Lankenau Institute for Medical Research (LIMR), is conducting a clinical trial for patients with Crohn’s Disease. Past work of Dr. Mullin’s group has shown that dietary restriction of the amino acid methionine can improve the junctional seals between epithelial cells. This holds the promise that dietary restriction of methionine may be able to improve intestinal linings of Crohn’s patients, thereby reducing their disease symptoms. - April 26, 2009 - Lankenau Institute for Medical Research

Innovation Award Nomination for Nanofibres Hair Camouflage

Hair loss is more prevalent than is often thought, incredibly, it is estimated that more than 30% of women will have noticeable thinning hair by the age of 50 and 50% of men by the age of 40. There are a few effective treatments, but they can take months, an innovative product can get you the results cosmetically, in seconds. - April 26, 2009 - Nanogen

Colorado BioScience Association Names Rick Jory Board Chair, Announces 2009 Sponsors and Appoints Seven New Board Members

Rick Jory, CEO of Sandhill Scientific, Inc., Highlands Ranch, was named chairperson of the board of directors for the Colorado BioScience Association (CBSA). He was appointed at the association’s 2009 annual meeting yesterday. Jory assumes chairperson responsibilities from Jack Wheeler, MicroPhage, Inc. In other action, seven new members were named to the CBSA board of directors. - April 23, 2009 - Colorado BioScience Association

TrialX Twitter Application Lets You Find Clinical Trials That Match Your Health Conditions with Its ‘Do It Yourself Model’

Trialx Twitter app lets you find matching clinical trials. With a simple tweet (i.e. @Trialx CT 55 yo female with multiple sclerosis), The app will tweet back with a link containing the matching trials, in less than 2 minutes. - April 20, 2009 - Applied Informatics

MicroTransponder CEO Will Rosellini to Testify Before the U.S. House of Representatives Concerning Neurotechnology

CEO Will Rosellini will testify before the U.S. House of Representatives regarding the Federal SBIR program on Wednesday, April 22. SBIR awards to MicroTransponder have funded neurotechnology research for TBI, Tinnitus, and PTSD resulting in potential new treatments for soldiers. - April 19, 2009 - MicroTransponder Inc.

Breakthrough Nanoindentation Testing with Image Pattern Recognition

Nanovea announced today a breakthrough development in Nanoindentation testing by combining advanced image pattern recognition capabilities to the most advanced nano-indenter for quality control applications. - April 18, 2009 - NANOVEA

Quintiles Named to Top 25 Canadian Employers List

Quintiles has been recognized by the Great Place to Work® (GPTW) Institute Canada as one of the top 25 companies to work for in the country. It is the first time Quintiles has made the Canadian GPTW list since the Institute’s awards were launched there in 2005. Quintiles is the... - April 17, 2009 - Quintiles

ThreeFold Sensors Honored as One of the 2009 "Michigan 50 Companies to Watch"

ThreeFold Sensors, an exciting new Michigan point-of-care diagnostic platform developer, today announced that it has been recognized as one of the 2009 “Michigan 50 Companies to Watch,” an awards program sponsored by the Edward Lowe Foundation and presented by Michigan Celebrates Small Business. - April 13, 2009 - ThreeFold Sensors

Advanced Orthopedics and Sports Medicine Institute (AOSMI) to Hold Open House for New Joint Center in Monroe, New Jersey

Advanced Orthopedics and Sports Medicine Institute of Freehold, New Jersey is opening a satellite office in Monroe Township. Medical services offered by AOSMI's new office will include sports medicine, hand and wrist care, shoulder and knee care, joint replacement, physiatry, fracture care, osteoporosis care, spine care, foot and ankle care, and work injury care. The public is invited to an open house event to tour the facility and meet the orthopedic surgeons on April 17 from noon to 4 p.m. - April 10, 2009 - Advanced Orthopedics and Sports Medicine Institute, PC

Unimed-Midwest Announces New Products: Flexible, Breathable Body Shield Body Supports Help Heal Injuries

New Body Shield body supports with advanced open cell Holofiber fabric are more effective and comfortable than neoprene-based supports. Body Shield body supports increase patients’ compliance, comfort and healing. - April 08, 2009 - Unimed-Midwest, Inc.

Healthcare Market Research: 50% Off Highlighted Market Research in Biotech, Healthcare, Nanotechnology and Biofuel

BioMarket Group have reduced the price on a number of featured healthcare market research reports by 50%. - April 03, 2009 - BioMarket Group

The First Oral Based Lead Test, LeadConfirm Professional, Makes Getting the Lead Out Easier

Aimed for the professional market, LeadConfirm Professional is less invasive than blood tests at detecting lead levels in the body. - April 02, 2009 - Confirm Biosciences

World's Leading Scientists Meet to Examine Barriers for Stem Cell Therapies to Cure Spinal Cord Injury

Following President Barack Obama's decision to lift the ban on federal funding for embryonic stem cell research, medical and scientific experts will converge at the University of Georgia to discuss how recent advances in stem cell research can be translated into cures for spinal cord injuries. The... - March 31, 2009 - Bedford Stem Cell Research Foundation

Massachusetts Scientists Make Stem Cell Discovery

Cell Multiplication Controlled by a Surprising set of Genes. Stem cell researcher Dr. Ann Kiessling has discovered that early human embryo cells express CLOCK, and other circadian genes, that other human cells growing in laboratories did not. This was a surprise. According to Professor Jose Cibelli of Michigan State University, "This is a seminal paper. I am sure we will be referring back to it 10, 20 years from now." - March 30, 2009 - Bedford Stem Cell Research Foundation

Can Cherries Relieve the Pain of Osteoarthritis? Patients in Pilot Study of Cherry Pills Experience Significant Pain Relief

For the estimated 27 million Americans who suffer from osteoarthritis, pain relief may come with a cherry on top. According to researchers with the Baylor Research Institute, tart cherries, in pill form, may be a promising pain-reliever for this common and debilitating form of arthritis. - March 27, 2009 - Baylor Research Institute

Prostate Cancer Solutions Without Surgery – A New Patient Guide for Surviving Prostate Cancer from the Dattoli Cancer Foundation

A new ‘Blue Ribbon’ prostate cancer solutions guidebook what surgeons don’t tell their patients: More men are now choosing high tech radiation therapies for prostate cancer treatment rather than surgery. The most up-to-date and comprehensive book on the subject examines all currently available prostate cancer solutions and explains how radioactive "seeds" and IMRT "smart beams" have made the scalpel and all other prostate cancer treatments increasingly obsolete. - March 21, 2009 - Dattoli Cancer Treatment Center

Colorado Bioscience Association Teams with Twenty-Six National & State Partners to Launch the ‘We Work for Health’ Initiative in Colorado

The Colorado BioScience Association is partnering with twenty-six national and state entities to announce the ‘We Work For Health’ initiative in Colorado. The launch event – Saving Lives, Creating Jobs -- occurs today at University of Colorado Denver, Anschutz Medical Campus in Aurora. U.S. Senator Michael Bennet is the special guest speaker. - March 20, 2009 - Colorado BioScience Association

Lankenau Institute for Medical Research Accelerates New Nanotherapy Platform for Treatment of Solid Tumors - Novel Delivery System Enters Preclinical Development Phase

The Lankenau Institute for Medical Research (LIMR) and its collaborating institution, the Massachusetts Institute of Technology (MIT), announced on March 9, 2009, that LIMR has been selected by the National Cancer Institute (NCI) for a research collaboration to perform preclinical studies on novel therapeutic nanoparticles for treatment of solid tumors. The research will be conducted by the NCI’s Nanotechnology Characterization Laboratory (NCL). - March 11, 2009 - Lankenau Institute for Medical Research

Early Phase Clinical Trials Leader Unveil Their New Portal to Comprehensive Clinical Trials Data Management

Richmond Pharmacology today launched their clinical trials data management portal signalling the establishment of a new era in clinical trials data management at Richmond Pharmacology. Designed by Data Management professionals from the Pharmaceutical industry with the needs of the Pharmaceutical industry in mind. - March 10, 2009 - Richmond Pharmacology Ltd

IonSense Announces the Greening of DART® Ion Source Technology

iPod Enabled Controller Facilitates Analysis with Nitrogen Gas, Simplifying Operation and Reducing Generation of Waste Products. - March 08, 2009 - IonSense, Inc.

World's Longest Prostate Cancer Cure Rates Published at Clinical Oncology Meeting

A long-term study revealing the longest reported Prostate Cancer Cure Rates in the world has been presented at the annual meeting of the American Society of Clinical Oncology in Orlando, last week. - March 08, 2009 - Dattoli Cancer Treatment Center

Press Releases 2,001 - 2,050 of 2,310